BioCentury

BioCentury This Week

Science EN ↓ 403 episodi

BioCentury's streaming commentary on biotech industry trends, plus interviews with KOLs. For three decades, BioCentury has helped biopharma executives and investors make business-critical decisions and build larger networks with peers across the innovation ecosystem.

Visita il sito del podcast e sostieni chi lo crea: www.biocentury.com

Autore

BioCentury

Categoria

Science

Sito del podcast

www.biocentury.com

Ultimo episodio

20 ott 2026

Dove ascoltare?

I podcast nell'app Replaio Radio In arrivo

I podcast stanno per arrivare nell'app. Installala ora e scopri per primo un modo tutto nuovo di vivere i podcast

Scaricala su Google Play Installala gratis Android quasi 10 mln di download · valutazione 4,8 iOS in arrivo

Episodi

Ep. 28 - FDA's Future & China Summit Preview 20.10.2020

Reach us by sending a text

Ep. 27 - CRISPR advances and mega-IPOs: a BioCentury podcast 13.10.2020

Reach us by sending a text

Ep. 26 - Treating Trump & BMS's $13B MyoKardia buy 06.10.2020

Reach us by sending a text

Ep. 25 - Alzheimer Milestones & Vaccine Politics 29.09.2020

Reach us by sending a text

Ep. 24 - Azar's Memo & Biotech's Deals 22.09.2020

Reach us by sending a text

Ep. 23 - $21B Deal by Gilead, None by PhRMA 15.09.2020

Reach us by sending a text

Ep. 22 - Back to School, Behind the Scenes 09.09.2020

Reach us by sending a text

Ep. 21 - FDA’s Credibility on the Line, plus Biotech’s Venture Wave 01.09.2020

Reach us by sending a text

Ep. 20 - Politics & Plasma 25.08.2020

Reach us by sending a text

Ep. 19 - I Want KaNDy, Plus Sputnik V & M&A amid COVID-19 17.08.2020

Reach us by sending a text

Ep. 18 - BIOEquality, Data Sharing and Deals 10.08.2020

Reach us by sending a text

Ep. 17 - Warp Speed, Decentralized Trials & SPACs 03.08.2020

Reach us by sending a text

Ep. 16 - Trump's Ultimatum, RADx & Preclinical IPOs 27.07.2020

Reach us by sending a text

Ep. 15 - Vaccine Hopes, the Shifting Biopharma Workplace & Blueprint's Dx Deal 21.07.2020

Reach us by sending a text

Ep. 14 - Investor Sentiment, HCQ Redux and Attacking AMR 14.07.2020

Reach us by sending a text

Ep. 13 - Nuances of NASH, COVID Vaccines and Real-World Data 06.07.2020

Reach us by sending a text

Ep. 12 - Remdesivir's Price, RWD’s Moment & A Genomics Breakup 29.06.2020

Reach us by sending a text

Ep. 11 - Funding U.K. Biotechs, plus Global Vaccine Access 23.06.2020

Reach us by sending a text

Ep. 10 - EUAs, ACTIV & M&A 16.06.2020

Reach us by sending a text

Ep. 9 - IPOs, Vaccines & BIO's New Leader 08.06.2020

Reach us by sending a text

Ep. 8 - Financing Flurry & Purchasing Pools 01.06.2020

Reach us by sending a text

Ep. 7 - FDA takes on COVID-19, plus ASCO's breakthroughs 27.05.2020

Reach us by sending a text

Ep. 6 - New Faces for COVID-19’s Next Phase, ASCO’s Hot Topics 19.05.2020

Reach us by sending a text

Ep. 5 - Master Protocols, EUAs and Rick Bright: BioCentury editors on COVID-19 12.05.2020

Reach us by sending a text

Ep. 4 - End of the beginning for vaccines and the post-pandemic future 05.05.2020

BioCentury editors discuss Goldilocks COVID-19 antibody test regulation, vaccine development, and the post-pandemic future. Reach us by sending a text

Ascolta il podcast BioCentury This Week su Replaio

Radio e podcast in un'unica app - gratis e senza registrazione. Installala oggi e non perderti il lancio

Scaricala su Google Play

Replaio non è un editore di podcast; i nomi dei programmi, le copertine e l'audio appartengono ai rispettivi autori e vengono distribuiti tramite feed RSS pubblici